Clinical use of the somatostatin analog SMS 201-995 in endocrinology.
Cozzi
R
R
Divisione di Endocrinologia, Ospedale Niguarda, Milano, Italy.
Liuzzi
A
A
Dallabonzana
D
D
Oppizzi
G
G
Orlandi
P
P
De Palo
C
C
Petroncini
M M
MM
Piolini
M
M
Chiodini
P G
PG
D000172:Acromegaly / Q000188:drug therapy; D007516:Adenoma, Islet Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000188:drug therapy*; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy; D013972:Thyrotropin / Q000378:metabolism
D013972:Thyrotropin; D015282:Octreotide